HLS announces that Vascepa is now reimbursed by British Columbia's Provincial Drug Plan

6 February 2024 - Public reimbursement for Vascepa is now available in Ontario, Quebec, British Columbia, Saskatchewan, New Brunswick, Northwest Territories, ...

Read more →

PHARMAC - 2023 in review

17 January 2024 - 2023 was yet another dismal year for New Zealanders in terms of them being able to ...

Read more →

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) receive public listing for patients with advanced endometrial carcinoma that is not MSI-H or dMMR

21 December 2023 - Merck and Eisai announce that Keytruda plus Lenvima, is now reimbursed with clinical criteria and conditions ...

Read more →

AbbVie announces provincial reimbursement for Vraylar (cariprazine) for the treatment of schizophrenia in Québec

17 April 2023 - AbbVie today announced that Vraylat is now listed as an exception medication status on the list of ...

Read more →

Mitsubishi Tanabe Pharma Canada receives engagement letter from Pan-Canadian Pharmaceutical Alliance for Radicava oral suspension

31 March 2023 - Mitsubishi Tanabe Pharma Canada is pleased to announce the company has entered into negotiations with the ...

Read more →

Quebec becomes first province to cover Brukinsa (zanubrutinib) for the treatment of Waldenström's macroglobulinemia

6 February 2023 - First and only Bruton's tyrosine kinase inhibitor to be granted provincial formulary approval. ...

Read more →

Santhera concludes agreement with French authorities on Raxone reimbursement and plans to submit a request for an early access program for vamorolone

8 February 2023 - Santhera Pharmaceuticals announces that it has secured a final reimbursement agreement with the French authorities related to ...

Read more →

Valeo Pharma obtains public reimbursement for Onstryv in Quebec

7 February 2023 - Quebec public reimbursement coverage to facilitate and expand medication access for Parkinson’s patients in Quebec. ...

Read more →

Medexus secures public reimbursement for Cuvposa in Quebec

1 February 2023 - Medexus Pharmaceuticals wishes to inform investors that the company has reached an agreement with the provincial government ...

Read more →

HLS announces that Vascepa is now reimbursed by Ontario's Provincial Drug Plan

25 July 2022 - Reimbursement for Vascepa in Canada is now at more than 65% for publicly covered lives and private ...

Read more →

German Government announces bill to drastically slash drug reimbursement

19 July 2022 - On 8 July 2022, the German Health Ministry has officially shared the second edition of a new ...

Read more →

Canada making progress in prescription drug coverage

13 July 2022 - Canada has seen a significant improvement in the number of Canadians eligible for some form of prescription ...

Read more →

Bluebird Bio has serious cash flow concerns; inability to strike reimbursement deals in Europe partly to blame

3 April 2022 - Bluebird bio is a highly innovative biotechnology company which develops gene therapies for several rare genetic ...

Read more →

Valeo Pharma secures additional public reimbursement for Redesca, Enerzair Breezhaler and Atectura Breezhaler

22 March 2022 - Canadian provincial public reimbursement now complete for Redesca with the addition of British Columbia. ...

Read more →

Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges

20 October 2021 - Medical devices are potentially good candidates for coverage with evidence development schemes, as clinical data at market ...

Read more →